Literature DB >> 23587836

Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.

Ronan Abgral1, Pierre-Yves Le Roux, Jean Rousset, Solène Querellou, Gérald Valette, Emmanuel Nowak, Alexandre Turzo, Valentin Tissot, Rémi Marianowski, Pierre-Yves Salaün.   

Abstract

OBJECTIVE: The objective of this study was to investigate the independent prognostic value of dual-time-point (18)F-fluorodeoxyglucose ((18)F-FDG) PET-CT imaging in patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: Patients referred to our department to undergo (18)F-FDG PET-CT for staging of HNSCC were prospectively included. Each patient was scanned using a Philips Gemini PET-CT system 1 h (early acquisition) and 2 h (delayed acquisition) after injection. An intratumoral retention index (RI) of (18)F-FDG was measured for each examination by the dual-time-point method. Event-free survival (EFS) and overall survival (OS) were determined by the Kaplan-Meier method and compared with the conventional maximum standardized uptake value (SUV(max)) at 60 min, SUV(max) at 120 min, and RI in univariate and multivariate analyses including the usual prognostic factors such as age, sex, primary site, SCC histologic grade, and American Joint Committee on Cancer stage (I, II, III, and IV).
RESULTS: Sixty-six consecutive patients (60 men and six women; mean age=61 ± 9 years) were included in the study. In univariate analysis, besides age and stage, RI was predictive of EFS (P=0.01) but not of OS (P=0.1), whereas SUV(max) at 60 min was not predictive of EFS (P=0.18) or OS (P=0.08) and SUV(max) at 120 min was predictive of OS (P=0.02) but not of EFS (P=0.05). In multivariate analysis, RI persisted as an independent predictive factor for EFS (P=0.02) but not SUV(max) at 120 min for OS (P=0.12).
CONCLUSION: Our results suggest an additional prognostic interest of RI measured by dual-time-point (18)F-FDG PET-CT, independent of usual prognostic factors, in patients with HNSCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587836     DOI: 10.1097/MNM.0b013e32836089ab

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  10 in total

Review 1.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

3.  Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.

Authors:  Byung Hyun Byun; Sung Hoon Kim; Sang Moo Lim; Ilhan Lim; Chang-Bae Kong; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Jae-Soo Koh; Soo Kyo Chung
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

4.  Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.

Authors:  Jon Cacicedo; Iratxe Fernandez; Olga Del Hoyo; Ainara Dolado; Javier Gómez-Suarez; Eduardo Hortelano; Aintzane Sancho; Jose I Pijoan; Julio Alvarez; Jose M Espinosa; Ayman Gaafar; Pedro Bilbao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-08       Impact factor: 9.236

5.  Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.

Authors:  Ronan Abgral; Nathalie Keromnes; Philippe Robin; Pierre-Yves Le Roux; David Bourhis; Xavier Palard; Jean Rousset; Gérald Valette; Rémi Marianowski; Pierre-Yves Salaün
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-07       Impact factor: 9.236

6.  The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT.

Authors:  Hansol Moon; Woo Chul Noh; Hyun-Ah Kim; Eun-Kyu Kim; Ko Woon Park; Seung Sook Lee; Joon Ho Choi; Kyung Woo Han; Byung Hyun Byun; Ilhan Lim; Byung Il Kim; Chang Woon Choi; Sang Moo Lim
Journal:  Nucl Med Mol Imaging       Date:  2016-04-11

7.  Radiotherapy volume delineation using dynamic [18F]-FDG PET/CT imaging in patients with oropharyngeal cancer: a pilot study.

Authors:  Antti Silvoniemi; Mueez U Din; Sami Suilamo; Tony Shepherd; Heikki Minn
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-01-25       Impact factor: 2.924

8.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study.

Authors:  Soo Jin Lee; Hyo Jung Seo; Gi Jeong Cheon; Ji Hoon Kim; E Edmund Kim; Keon Wook Kang; Jin Chul Paeng; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

9.  The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma.

Authors:  Natsuki Yonezawa; Tsutomu Minamikawa; Kazuhiro Kitajima; Yusuke Takahashi; Ryohei Sasaki; Ken-Ichi Nibu; Takahide Komori
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

Review 10.  Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.

Authors:  Renata Fockink Dos Anjos; Dalton Alexandre Dos Anjos; Danielle Leal Vieira; André Ferreira Leite; Paulo Tadeu de Souza Figueiredo; Nilce Santos de Melo
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.